Skip to main content
SpringerLink
Log in

Testosterone products: increased risk of stroke and MI?

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • FDA. FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. Internet Document : 3 Mar 2015. Available from: URL: http://www.fda.gov/Drugs/DrugSafety/ucm436259.htm

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Testosterone products: increased risk of stroke and MI?. Reactions Weekly 1543, 6 (2015). https://doi.org/10.1007/s40278-015-8630-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-8630-4

Search

Navigation